Mark For: TRUNAV™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 97718671 |
Mark Literal Elements | TRUNAV |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark, Service Mark |
Current Location | NEW APPLICATION PROCESSING 2022-12-19 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Constance B. Stefanou |
2022-12-15 | Application Filed |
2022-12-19 | Location: NEW APPLICATION PROCESSING |
2022-12-19 | Status: Live/Pending |
2022-12-19 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
2022-12-19 | Transaction Date |
Party: | True Bearing Diagnostics, Inc. |
Address | 2450 Virginia Avenue, NW, Suite # E117 Washington, DISTRICT OF COLUMBIA UNITED STATES 20037 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, Atherosclerotic load risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing guidance for hypercholesterolemia treatment; medical analysis for the treatment of coronary artery disease (CAD); healthcare |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-12-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.